Diagnosis and Treatment of Different Types of Anemia
The most effective approach to anemia management requires accurate diagnosis of the specific type followed by targeted treatment, with iron deficiency anemia typically treated with 60-120 mg daily oral iron for adults and 3 mg/kg/day for children until hemoglobin normalizes and for 2-3 months thereafter to replenish stores.
Diagnostic Approach
Initial Evaluation
- Complete blood count (CBC) with hemoglobin, hematocrit, and mean corpuscular volume (MCV) is essential for initial classification 1
- Anemia can be effectively classified using MCV and reticulocyte count to determine if bone marrow can respond by increasing erythropoiesis 2
- Serum ferritin below 15 μg/L confirms iron deficiency anemia 1
Classification Based on MCV and Reticulocytes
Microcytic anemia (low MCV):
Normocytic anemia (normal MCV):
Macrocytic anemia (high MCV):
Treatment of Iron Deficiency Anemia
Oral Iron Therapy
- Adults: Prescribe 60-120 mg/day of elemental iron 2, 3
- Children: Administer 3 mg/kg per day of iron drops between meals 2
- Duration: Continue treatment for 2-3 months after hemoglobin normalizes to replenish iron stores 2, 3
- Expected response: Hemoglobin should increase by approximately 2 g/dL after 3-4 weeks of treatment 3
- Follow-up: If anemia doesn't respond after 4 weeks despite compliance, further evaluate with MCV, RDW, and serum ferritin 2
Formulation and Dosing Strategies
- Ferrous sulfate 200 mg once daily (providing approximately 65 mg elemental iron) is the preferred oral formulation due to effectiveness and low cost 3
- Once-daily dosing is recommended over multiple daily doses to improve tolerance 3, 4
- Adding vitamin C can enhance iron absorption when response is poor 3
- Alternative formulations like ferrous gluconate and ferrous fumarate may be better tolerated in some patients 3, 5
Intravenous Iron Therapy
- Indicated for patients who cannot tolerate oral iron despite trying different preparations 3
- Recommended for inadequate response to oral iron therapy after 4 weeks 3
- First-line for patients with inflammatory bowel disease and severe anemia (Hb <10 g/dL) 2, 3
- Preferred for conditions affecting iron absorption (inflammatory bowel disease with active inflammation, celiac disease) 3
Treatment of Vitamin B12 Deficiency
Parenteral Treatment
- For pernicious anemia: 100 mcg daily for 6-7 days by intramuscular injection 6
- If clinical improvement occurs: 100 mcg on alternate days for seven doses, then every 3-4 days for 2-3 weeks 6
- Maintenance: 100 mcg monthly for life 6
- Folic acid should be administered concomitantly if needed 6
Oral Treatment
- For patients with normal intestinal absorption, oral B12 preparation is appropriate for chronic treatment 6
- Avoid intravenous route as most of the vitamin will be lost in urine 6
Treatment of Folate Deficiency
- Dosage: Up to 1 mg daily for adults and children 7
- Maintenance: 0.1 mg for infants, up to 0.3 mg for children under 4 years, 0.4 mg for adults and children 4+ years, and 0.8 mg for pregnant and lactating women 7
- Duration: Continue until blood picture becomes normal, then maintain on appropriate dose 7
- Special considerations: Higher maintenance doses may be needed with alcoholism, hemolytic anemia, anticonvulsant therapy, or chronic infection 7
Special Populations
Pregnant Women
- Screen for anemia at first prenatal visit 2
- Start low-dose (30 mg/day) iron supplements at first prenatal visit 2, 1
- For anemia treatment, prescribe 60-120 mg/day of iron 2, 1
- Refer pregnant women with Hb <9.0 g/dL for further medical evaluation 2, 3
Inflammatory Bowel Disease Patients
- Intravenous iron is first-line treatment for clinically active IBD with Hb <10 g/dL 2, 3
- For mild anemia in inactive disease, oral iron may be used 2
- No more than 100 mg elemental iron per day is recommended 2
- Monitor for recurrent iron deficiency every 3 months for at least a year after correction 2
Myelodysplastic Syndromes
- Erythropoiesis-stimulating agents (ESAs) are first-line treatment for anemia in lower-risk MDS without del(5q) 2
- For lower-risk MDS with del(5q), lenalidomide is effective in 60-65% of patients 2
- Iron chelation should be considered in patients with systemic iron overload 2
Common Pitfalls to Avoid
- Failing to treat the underlying cause of iron deficiency while supplementing iron 3
- Continuing oral iron despite poor tolerance or inadequate response 3
- Using multiple daily doses of oral iron, which increases side effects without improving efficacy 3, 4
- Overlooking the need for vitamin C supplementation to enhance iron absorption 3
- Failing to continue iron therapy for 2-3 months after correction of anemia 2, 3
- Not considering alternative diagnoses when anemia doesn't respond to appropriate iron therapy 2